Condition-Specific Health
Enterome's OncoMimics™ EO2463 Drives CD8 T Cell Response in Phase 1/2 Lymphoma Study
Microbiome-mimicry immunotherapy edges toward clinical validation — with implications for how gut-derived peptides may …
Condition-Specific Health 103 stories
Condition-Specific Health
Barzolvolimab Phase 2 Data Show Durable CSU Remission Off-Treatment
Celldex's anti-KIT monoclonal antibody moves the goalposts from symptom control to potential disease modification — a s…
Condition-Specific Health
Lorundrostat Linked to Heart Failure Biomarker Reductions in Proteomic Analysis
Late-breaking findings presented at the Endocrine Society Annual Meeting add cardiovascular biomarker evidence to the a…
Condition-Specific Health
Verekitug Phase 2 Data Show 80% Responder Rate in Nasal Polyp Trial
The EAACI 2026 responder analysis adds to mounting evidence for targeted biologics in upper-airway inflammatory conditi…
Condition-Specific Health
Setmelanotide Phase 2 Data Show BMI, Fat Mass Gains in PWS
Six-month interim results reinforce MC4R pathway as a viable therapeutic target, with Phase 3 development now in the ra…
Condition-Specific Health
Pharmacist Education Targets Clinical Inertia in Type 2 Diabetes Care
As GLP-1 adoption accelerates, new CE data highlights the pharmacist's expanding role in bridging gaps between clinical…
Condition-Specific Health
Bucked Up Marks 10 Years With Sitewide Anniversary Sale
The Utah-based brand has expanded from a single deer antler spray SKU to a full portfolio spanning pre-workouts, creati…
Condition-Specific Health
Cogent Biosciences Reports 65% ORR for Bezuclastinib in AdvSM Trial
Phase 3 APEX data presented at EHA 2026 positions the KIT-targeting agent as a potential standard-of-care option in a r…
Condition-Specific Health
Sovleplenib Phase III Data Show Durable Hemoglobin Response in AIHA
HUTCHMED's spleen tyrosine kinase inhibitor advances clinical evidence base as targeted hematology therapies draw renew…
Condition-Specific Health
MagnaWave PEMF Launches M Line With Enhanced Field Control
As PEMF devices edge into recovery and biohacking categories, operator-grade reliability becomes a key differentiator f…
Condition-Specific Health
CB-011 CAR-T Reports 83% Complete Response in Myeloma Trial
Single-dose durability data from EHA 2026 positions off-the-shelf CAR-T as a potential paradigm shift in hematologic on…
Condition-Specific Health
Loma Linda & Nudj Health Launch Whole-Person Primary Care Model
The partnership signals growing institutional appetite for lifestyle-medicine frameworks that embed nutrition and funct…